North Texas Renal Management V
Dallas, US · Founded 2017 · Texas LLC
Founders & leadership
GW

Geoffrey Walker, M.D.inExecutive
SG
Steven Gieser, M.D.Executive
AL
Alexander Liang, M.D.Named on SEC filing
AS
Anupkumar Shetty, M.D.Named on SEC filing
JM
Joris M Schuller, Jr., M.D.Named on SEC filing
Board
DR
Daniel Richey, D.O.Board director
JM
Jyothsna M. Kodali, M.D.Board director
AK
Ali Khalil, M.D.Board director
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 4 rounds · 2017–2025
▶$102.5KraisedApr 2026 · 1 investors · Other Health CareRule 506(b)
▶$102.5KraisedApr 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven M. GieserExecutive Officer, Director
- Daniel RicheyDirector
- Jyothsna KodaliExecutive Officer, Director
- Geoffrey S. WalkerExecutive Officer, Director
- Ali KhalilDirector
- Offering amount
- $2.6M
- Amount sold
- $102.5K
- First sale
- Dec 2025
- Incorporated
- Limited Liability Company, Texas
- Federal exemptions
- 06b
▶$116.3KraisedJan 2025 · 1 investors · Other Health CareRule 506(b)
▶$116.3KraisedJan 2025 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel Richey, D.O.Director
- Jyothsna M. Kodali, M.D.Director
- Ali Khalil, M.D.Director
- Geoffrey Walker, M.D.Executive Officer, Director
- Steven Gieser, M.D.Executive Officer, Director
- Offering amount
- $2M
- Amount sold
- $116.3K
- First sale
- Dec 2024
- Incorporated
- Limited Liability Company, Texas
- Federal exemptions
- 06b
▶$388.8KraisedJan 2024 · 4 investors · Other Health CareRule 506(b)
▶$388.8KraisedJan 2024 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jyosthsna Kodali, M.D.Director
- Alexander Liang, M.D.Executive Officer, Director
- Steven M. Gieser, M.D.Executive Officer, Director
- Geoffrey Walker, M.D.Executive Officer, Director
- Daniel Richey, D.O.Director
- Offering amount
- $2M
- Amount sold
- $388.8K
- First sale
- Dec 2023
- Incorporated
- Limited Liability Company, Texas
- Federal exemptions
- 06b
▶$738.5KraisedNov 2017 · 63 investors · Other Health CareRule 506(b)
▶$738.5KraisedNov 2017 · 63 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alexander Liang, M.D.Director
- Geoffrey Walker, M.D.Executive Officer, Director
- Anupkumar Shetty, M.D.Executive Officer, Director
- Steven Gieser, M.D.Executive Officer, Director
- Joris M Schuller, Jr., M.D.Director
- Offering amount
- $959.3K
- Amount sold
- $738.5K
- Minimum investment
- $5.8K
- First sale
- Oct 2017
- Incorporated
- Limited Liability Company, Texas, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has North Texas Renal Management V raised?
- North Texas Renal Management V has disclosed $1.3M raised across 4 rounds.
- Where is North Texas Renal Management V headquartered?
- North Texas Renal Management V is headquartered in Dallas, US.